Document is current

Any future updates will be listed below

339 Engineered T cell therapy combined with PD-1, Lag-3 and Tim-3 checkpoint inhibition promotes pro-inflammatory CD4 T cell differentiation in an ovarian cancer mouse model

Crossref DOI link: https://doi.org/10.1136/jitc-2025-SITC2025.0339

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark